FHTX NASDAQ
Foghorn Therapeutics Inc.
1W: -42.3%
1M: -60.9%
3M: -60.0%
YTD: -61.1%
1Y: -59.0%
3Y: -66.3%
5Y: -85.8%
$2.02
-0.90 (-30.82%)
Weekly Expected Move ±17.6%
$1
$2
$2
$2
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships6
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2021-12-13
Earliest Filing
2025-07-01
Latest Filing
partner: 6
Counterparties (Filed by FHTX)
6 relationshipsCompanies named in FHTX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| ARE-MA Region No. 77, LLC | — | partner | Landlord for new lease agreement at 99 Coolidge Avenue, Watertown, MA | 2025-07-01 | View |
| ARE-Tech Square, LLC | — | partner | Prior Landlord for terminated lease agreement at 500 Technology Square, Cambridge, MA | 2025-07-01 | View |
| Jefferies LLC | JEF | partner | Underwriter for the public offering of common stock and pre-funded warrants | 2024-05-22 | View |
| Evercore Group L.L.C. | EVR | partner | Underwriter for the public offering of common stock and pre-funded warrants | 2024-05-22 | View |
| Cowen and Company, LLC | — | partner | Sales agent for at-the-market offering of common stock | 2022-04-15 | View |
| Eli Lilly and Company | LLY | partner | Entered into a collaboration agreement and stock purchase agreement for joint development, licensing, and equity investm | 2021-12-13 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-01 | Exit/Disposal Costs; Regulation FD; Exhibits | View | |
| 2026-08-06 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-06-24 | Shareholder Vote | View | |
| 2026-05-07 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-04-21 | Regulation FD; Other Events; Exhibits | View | |
| 2026-03-11 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-02-23 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta | View | |
| 2025-12-04 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-11-07 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-05 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2025-10-30 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-09-02 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-08-05 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-07-01 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Financial St | Agreement | View |
| 2025-06-17 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-14 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-05-01 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2025-04-28 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-03-24 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR